To Compare the result of Gomutra haritaki churna and kanchanar churna along with mulakadi taila uttarbasti in Garbhashaya Arbuda.

Phase 2

Not yet recruiting

Conditions: Leiomyoma of uterus, unspecified. Ayurveda Condition: ARBUDAH,

Registration Number: CTRI/2025/05/087643

Lead Sponsor: Madan Mohan Malviya Govt. Ayurved College Udaipur

Brief Summary: The most common benign tumour of the uterus is the uterine fibroid. Despite not being malignant, it can have a negative impact on women’s overall health and quality of life. Among women over 30 years the disease has a 20% prevalence These are more prevalent in nulliparous couples or infertile individuals with one kid. Gynaecologist often deal with uterine fibroids in their daily practice. Oral medication, hormonal therapy, hysterectomy, and other therapeutic techniques are used to treat uterine fibroids, but they are less effective, and patients find it difficult to accept hysterectomy .Due to Modern science limitation, Ayurveda has great scope in the field to find out effective and invasive approach to manage the disease and improve the quality of life This Study is about to Randomized Comparative Clinical Study to Evaluate the Efficacy of Gomutra Haritaki Churna and Kanchanar Churna along with Mulakadi taila Uttara basti on Garbhashaya Arbuda W.S.R. to Uterine Fibroid There will be Two Group of 30 Patient. Group A Patient will be treated with Gomutra Haritaki Churna 3 gm BD and 5 ml mulkadi Taila Uttarbasti Basti (per vaginal) for 3 days for 3 consecutive menstrual cycle. while other 30 patients of group B will be treated with 3 gm BD kanchanar churna and 5 ml mulkadi Taila uttara Basti (per vaginal for 3 days for 3 consecutive menstrual cycle. This trial study will be carried out for 3 months (90 days) & the follow up of the case will be after every 15 days. Final assessment will be done after completion of 3 months of treatment course on the basis of subjective, objective assessment and laboratory investigations.The data

will be analyzed scientifically and statistically.

Detailed Description: Not available

Recruitment & Eligibility

Status: Not Yet Recruiting

Sex: Female

Target Recruitment: 60

Inclusion Criteria

1.Patient who are willing for trial 2.Single or multiple uterine fibroid 3.The patient either asymptomatic or having clinical sign and symptoms of fibroid.

Exclusion Criteria

1.Patient having bleeding due to abortion or any other pathological condition 2.Patients having coagulation disorders.
3.Patient of age less than 30 years and above 50 years 4.Pregnant women 5.Anemic patient whose hemoglobin is below 7 gm.% 6.Patient having any systemic disease like uncontrolled hypertension, diabetes mellitus 7.Patient using IUCDs 8.Having any kind of malignancy.
9.Patient with positive VDRL, HIV, HbsAg, 10.Patients who are contraindicated for Uttar Basti.
11.Large size uterine fibroid with severe menorrhagia and severe pressure symptoms.

Study & Design

Study Type: Interventional

Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
To compare the effect of trial drug and procedure to Change in the size and volume of uterine fibroid	90 days

Secondary Outcome Measures

Name	Time	Method
To compare the effect of trial drug and procedure on clinical features of the Garbhashaya Arbuda	90 days

Trial Locations

Locations (1): Madan Mohan Malviya Govt. Ayurved College Udaipur
🇮🇳
Udaipur, RAJASTHAN, India
Madan Mohan Malviya Govt. Ayurved College Udaipur
🇮🇳Udaipur, RAJASTHAN, India
Dr Ritasha Dubey
Principal investigator
06376050230
dr.ritasha.dubey@gmail.com